How Glenmark’s AbbVie deal is setting a new standard for Indian Pharma’s R&D AmbitionsCan this $700 million AbbVie deal pave the way for India to lead in global biotech innovation?
On July 10, 2025, Glenmark Pharmaceuticals struck one of the largest licensing deals in Indian biotech history. The deal involves their investigational cancer treatment,...